Navigation Links
Ipsogen Launches a New Test to Determine Tumor HER2 Status and Guide Herceptin(R) Prescription in Breast Cancer
Date:11/24/2008

MARSEILLE, France, November 24 /PRNewswire-FirstCall/ -- IPSOGEN SA (Marseille, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukemia and breast cancer announced today the European launch of MapQuant Dx(TM) HER2 test. Developped on the MapQuant Dx(TM) microarray diagnostic platform, MapQuant Dx(TM) HER2 accurately measures a set of HER2-amplified genes that correlate with HER2 protein expression. This new HER2 test provides reliable, intelligible and decisive information for pathologists, oncologists and patients.

"MapQuant(TM) Dx HER2 is the second test to be developped on our MapQuant Dx(TM) platform, after the Genomic Grade launched by Ipsogen earlier this year. Thanks to our experience in molecular diagnostics and to multiple research collaborations, we will keep delivering innovative tests at an accelarated pace." says Dr. Jean-Marc Le Doussal, Director of the Breast Cancer Program at Ipsogen.

Commenting on its experience with Ipsogen, Pr. Francois Bertucci, Medical Oncologist at Institut Paoli Calmettes Cancer Center in Marseille adds: "I was very pleased to collaborate with Ipsogen in rapidly and efficiently moving from our research findings to a market-ready diagnostic test. As a translational researcher, I believe that MapQuant Dx(TM) is a comprehensive "plug & play" solution, making research rapidly available to patients".

About MapQuant Dx(TM) HER2

Clinical Rationale

The amplification of the HER2-region of chromosome 17 results in the constitutive overexpression of the HER2 oncogene protein and fuels uncontroled tumor growth in approximately 15 to 30% of breast tumors. HER2 is considered today as a predictive marker for clinical benefit from trastuzumab, or Herceptin(R), a monoclonal antibody directed against the HER2 protein, in both primary and metastatic tumors. However current testing methods are inaccur
'/>"/>

SOURCE Ipsogen SA
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer
2. Isogen Launches Major New Facility to Address Global Biopharma Demand
3. Oramed Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository
4. Photos: NIH Launches New Web Site for Parents on Medical Research Studies for Children
5. Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain
6. Xalieve(TM) Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients
7. Good Samaritan Hospital Launches High Risk Breast Cancer Program at Good Samaritan North Health Center
8. Coapt Systems Launches FDA Cleared Novielle Voice (TM) for Restoration of Voice Loss
9. Oramed Pharmaceuticals Launches GLP1-Analog Program, Based on its Proprietary Drug Delivery Platform
10. Agendia Launches TargetPrint(R) for Breast Cancer Patients
11. Aon eSolutions Launches Clinical Trials Module
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... -- Misonix, Inc. (NASDAQ: MSON ), an international ... innovative therapeutic ultrasonic instruments for spine surgery, neurosurgery and ... financial results for the first quarter fiscal year 2015 ... a conference call that same day, Thursday, November 6, ... Interested parties can access the conference ...
(Date:10/30/2014)... N.J. , Oct. 30, 2014 Stryker ... TOUR and Champions Tour, is rounding out its debut ... Championship in Scottsdale, AZ. This ... TOUR and Champions Tour that the brand has activated ... designed to educate golf fans on the importance of ...
(Date:10/30/2014)... Oct. 30, 2014   NxStage® Kidney Care, Inc ., ... ), is proud to host the grand opening ceremony of ... 1600 W. 16 th Street on November 20, 2014 ... highly trained medical staff who are committed to providing patients ... life benefits made possible through more flexible dialysis treatment options.   ...
Breaking Medicine Technology:Misonix, Inc. To Report First Quarter Fiscal Year 2015 Financial Results On Thursday, November 6, 2014 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 2Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 3Stryker Mobility Zone Makes Final Stop Of 2014 At Charles Schwab Cup Championship 4Grand Opening of NxStage Kidney Care Oak Brook IL Center 2Grand Opening of NxStage Kidney Care Oak Brook IL Center 3
... 1b study planned for mid 2008 with Phase 2 development ... to begin late in 2008 or in early ... NUVO ) today announced positive results from the Phase 1,proof-of-concept ... offset of anticoagulation after,a single bolus dose with a favorable safety ...
... Erythematosus ... ... (Nasdaq: RIGL ) announced today that its lead product,candidate, R788, ... reported in a recently published,study of the drug candidate. R788 (fostamatinib ...
Cached Medicine Technology:Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 2Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 3Nuvelo Announces Positive Proof-of-Concept Data With Anticogulant NU172 4Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 2Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 3Rigel's R788 Slows Progression of Murine Lupus in Preclinical Studies 4
(Date:10/30/2014)... Indialantic, FL (PRWEB) October 30, 2014 ... products, vitamins, supplements, weight loss aids, and more, is ... The sweepstakes, which is already underway, is open to ... until midnight on December 15, 2014. One lucky winner ... entries to receive a $100 gift card to NutritionLeaders.com. ...
(Date:10/30/2014)... Pompano Beach, Florida (PRWEB) October 30, 2014 ... surprise Halloween visit to Pompano Beach firefighters, showing that ... your community. , Timothy met firefighters Tracey and ... sponsored by Galuppi’s Restaurant and the Pompano Beach Chamber ... and outside the fire truck, letting Timothy wear his ...
(Date:10/30/2014)... October 30, 2014 Graphics, coding, typography ... synonymous with the craft of web design and require ... Yet a simpler solution to create a website can ... videos, contact information, customer reviews and Facebook posts all ... "It is the next evolution of how a business ...
(Date:10/30/2014)... 2014 Don Allred Insurance, a leading ... plans for North Carolina residents, is excited to announce ... Holly Hill Mall. The new branch has been up ... customers through all facets of the insurance selection process ... spokesman Scott Allred couldn’t be happier with the timing ...
(Date:10/30/2014)... Calif. (PRWEB) October 30, 2014 ... mutually exclusive concepts in the medical-grade skin care ... the development of uniquely potent topical dermatological products, ... System ( http://www.RefinitySkinScience.com ) with patented COSMEDERM®-7 anti-irritant ... glycolic acid concentrations (50% and 70%) and a ...
Breaking Medicine News(10 mins):Health News:Nutrition Leaders Announces Gift Card Sweepstakes 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 2Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 3Health News:4-year-old InstaKNOT CEO Honors Local Firefighters with Community Support 4Health News:Facebook Websites In Thirty-Seconds 2Health News:Allred Insurance Satellite Office Grand Opening 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 2Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 3Health News:Cosmederm Redefines Peel Science Standard with Launch of Refinity® Skin Health System 4
... of times our cells can divide is dictated by telomeres, ... how telomeres keep our chromosomes and by extension, our ... in the fields of both aging and cancer. Now, scientists ... on the structure and function of a crucial domain in ...
... and the UCLA Henry Samueli School of Engineering and ... of Homeland Security,s Science and Technology Directorate to help ... in the field. The UCLA team will work ... on the agency,s PHASER (Physiological Health Assessment System for ...
... Reporter , WEDNESDAY, Sept. 15 (HealthDay News) -- Fresh on the ... study shows that men who have a low prostate-specific antigen (PSA) ... men with a high PSA reading -- 2 nanograms per milliliter ... risk of developing the disease, the researchers added. "If ...
... risk of cardiovascular disease, stroke, high blood pressure, or ... International Journal of Data Mining, Modelling and Management . ... network computer program to analyze patient data and spot ... for an individual. Khanna Nehemiah of the Anna ...
... HealthDay Reporter , TUESDAY Sept. 14 (HealthDay News) -- A ... has sickened a handful of people in North America, with ... officials said Tuesday. But the bacterium -- designated ... of another bacterium that,s been present in the United States ...
... by Indiana University and Columbia University researchers found no ... mental illness or substance abuse problems despite a greater ... illnesses. The study, published online Sept. 15 ... vexing questions about the effectiveness of campaigns designed to ...
Cached Medicine News:Health News:Protein clamps tight to telomeres to help prevent aging...and support cancer 2Health News:Protein clamps tight to telomeres to help prevent aging...and support cancer 3Health News:UCLA selected by Homeland Security to help establish guidelines for firefighter health and safety 2Health News:Men With Low PSA at 60 Might Not Need Further Screening 2Health News:Men With Low PSA at 60 Might Not Need Further Screening 3Health News:Fuzzy thinking could spot heart disease risk 2Health News:New Drug-Resistant 'Superbug' Reaches U.S. Shores 2Health News:New Drug-Resistant 'Superbug' Reaches U.S. Shores 3Health News:Study: Mental illness stigma entrenched in American culture; new strategies needed 2Health News:Study: Mental illness stigma entrenched in American culture; new strategies needed 3
An enzyme linked immunoassay (ELISA) for the detection and semiquantitation of IgG, IgA or IgM anticardiolipin antibodies, as an aid in assessing the risk of thrombosis in individuals with Systemic L...
... Research Grade Microscope Camera from ImagingPlanet ... imaging technology that delivers increased image ... an affordable price. Document, Archive ... 3.3 mega-pixel digital microscope camera designed ...
The ImagingPlanet 70 mm surgical microscope video adapter: Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgica...
The ImagingPlanet 55 mm surgical microscope video adapter: superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical ...
Medicine Products: